Moderna
MRNA
#1404
Rank
HK$123.63 B
Marketcap
HK$316.41
Share price
2.47%
Change (1 day)
15.63%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: HK$123.63 Billion

As of January 2026 Moderna has a market cap of HK$123.63 Billion. This makes Moderna the world's 1404th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$123.63 B30.34%
2025HK$94.85 B-20.88%
2024HK$119.88 B-59.52%
2023HK$296.14 B-45.07%
2022HK$539.16 B-32.85%
2021HK$802.96 B150.55%
2020HK$320.47 B525.11%
2019HK$51.26 B30.39%
2018HK$39.31 B

End of Day market cap according to different sources

On Jan 13th, 2026 the market cap of Moderna was reported to be:

HK$120.62 Billion
by Nasdaq info icon info icon
HK$120.64 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regulus Therapeutics
RGLS
HK$4.40 B-96.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$2.161 T 1,648.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
HK$6.49 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$377.90 B 205.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$2.186 T 1,668.74%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
HK$71.64 B-42.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$4.105 T 3,220.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
HK$23.21 B-81.22%๐Ÿ‡บ๐Ÿ‡ธ USA